Organomix Research India Profile
Key Indicators
- Authorised Capital ₹ 1.60 Cr
- Paid Up Capital ₹ 1.28 Cr
- Company Age 19 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 9.32%
- Profit Growth -55.77%
- Ebitda -34.53%
- Net Worth -30.93%
- Total Assets -0.25%
About Organomix Research India
Organomix Research India Private Limited (ORIPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 September 2005 and has a history of 19 years and four months. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.60 Cr and a paid-up capital of Rs 1.28 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kamala Raghunathan and Subha Sanjeev serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231TN2005PTC057500
-
Company No.
057500
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Sep 2005
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Organomix Research India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subha Sanjeev
|
Director | 09-Jul-2021 | Current |
|
Kamala Raghunathan
|
Director | 07-Jul-2021 | Current |
Financial Performance of Organomix Research India.
Organomix Research India Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.32% increase. The company also saw a substantial fall in profitability, with a 55.77% decrease in profit. The company's net worth observed a substantial decline by a decrease of 30.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Organomix Research India?
In 2023, Organomix Research India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
National Schools Of Business And Management Private LimitedKamala Raghunathan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Organomix Research India?
Unlock and access historical data on people associated with Organomix Research India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Organomix Research India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Organomix Research India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
